The Bioinformatics CRO Podcast Nick Wisniewski - AI and the future of biotechnology
Jan 21, 2025
Nick Wisniewski, VP of Bioinformatics at Stemson Therapeutics, shares insights from his journey in cell therapy and AI's role in drug development. He emphasizes the need for curiosity in scientific pursuits over rigid goals. Wisniewski discusses the importance of generalization for collaboration and the integration of AI in biotechnology, including gene modeling and ethical considerations. He also reflects on innovative regenerative medicine practices, blending his diverse scientific background from particle physics to cardiology.
AI Snips
Chapters
Books
Transcript
Episode notes
Early Influences
- Nick Wisniewski's early exposure to science and computing began at age four with a Texas Instruments computer.
- This sparked an interest in programming and a passion for music, influencing his career path.
Disruptive Curiosity
- Nick's interest in quantitative science began with chemistry, leading him to explore quantum mechanics and physics independently.
- His inquisitive nature led to him studying advanced concepts and pursuing a scientific career.
Discouraged from Theory
- During his graduate school search, Nick was surprisingly discouraged from pursuing theoretical physics due to job prospects.
- This advice, along with other factors, influenced his decision to shift his focus away from particle physics.
